Posted in new developments

ANTITUMOR DRUG “AMITOZIN”

 Wednesday July 15th, 2020

PURPOSE:

For the prevention and treatment of malignant tumors.

TECHNICAL SPECIFICATIONS:

The product of the alkylation of ThioTEF alkaloids of the celandine of large Chelidonium majus L.

ADVANTAGES:

Amitozin has no analogues in the world. The drug does not have an immunosuppressive effect, does not inhibit hematopoiesis, has an immunomodulating and carcinolytic effect. The prolonged administration of therapeutic doses does not lead to a toxic effect. Tenfold administration of the drug in a dose of 1 / 10-1 / 16 LD 50 does not lead to pathological changes in internal organs. A clinical study of Amitozin in a number of clinics in Ukraine on incurable cancer patients of the III and IV stages of cancer of the prostate, ovary, esophagus, mesothelioma, etc. showed the presence of an antitumor effect of the drug in about 75% of cases.

RECOMMENDED FIELD OF APPLICATION:

Medicine.

RESULTS OF THE RESEARCH:

Ready for implementation.

STAGE OF THE DEVELOPMENT READINESS::

Ready for implementation.

TRANSFER OPPORTUNITY:

    • Joint bringing to the industrial level.
    • Establishment of a joint venture.

NOVELTY:

1 patent of Ukraine.

 

IF YOU ARE INTERESTED IN THIS DEVELOPMENT, PLEASE,

WRITE TO US

4 thoughts on “ANTITUMOR DRUG “AMITOZIN””

  1. Интересует препарат АМИТОЗИН, прежде всего стоимость (я пенсионер) и где его можно приобрести, я сам из Киева.
    Заранее благодарен за ответ,
    Виктор

    1. Здравствуйте. Я думаю, лучше всего эту информацию знает разработчик преперата. Отправила данные Вам на почту. С уважением, Ирина.

  2. Добрый день, имею проблемы с онкологией,заинтересован в препарате.Где и как можно приобрести?

    1. Здравствуйте. Я думаю, лучше всего эту информацию знает разработчик преперата. Отправила данные Вам на почту. С уважением, Ирина.

Comments are closed.